# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001600620-23-000005
Filing Date
2023-04-18
Accepted
2023-04-18 16:24:57
Documents
27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | auph-20230418.htm iXBRL | DEF 14A | 1505254
6 |  | auph-20230418_g1.jpg | GRAPHIC | 11010
7 |  | auph-20230418_g10.jpg | GRAPHIC | 110000
8 |  | auph-20230418_g11.jpg | GRAPHIC | 129145
9 |  | auph-20230418_g12.jpg | GRAPHIC | 108654
10 |  | auph-20230418_g13.jpg | GRAPHIC | 38273
11 |  | auph-20230418_g2.jpg | GRAPHIC | 33931
12 |  | auph-20230418_g3.jpg | GRAPHIC | 183904
13 |  | auph-20230418_g4.jpg | GRAPHIC | 93004
14 |  | auph-20230418_g5.jpg | GRAPHIC | 169706
15 |  | auph-20230418_g6.jpg | GRAPHIC | 170621
16 |  | auph-20230418_g7.jpg | GRAPHIC | 118815
17 |  | auph-20230418_g8.jpg | GRAPHIC | 108244
18 |  | auph-20230418_g9.jpg | GRAPHIC | 105660
| Complete submission text file | 0001600620-23-000005.txt |  | 5634750

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | auph-20230418.xsd | EX-101.SCH | 4536
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | auph-20230418_def.xml | EX-101.DEF | 6120
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | auph-20230418_lab.xml | EX-101.LAB | 9582
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | auph-20230418_pre.xml | EX-101.PRE | 5717
21 | EXTRACTED XBRL INSTANCE DOCUMENT | auph-20230418_htm.xml | XML | 145332

Mailing Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6
Business Address #140, 14315 - 118 AVENUE EDMONTON A0 T5L 4S6 250-744-2487
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

EIN.: 981231763 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36421 | Film No.: 23827147
SIC: 2834 Pharmaceutical Preparations